Avanos Medical (NYSE:AVNS) is a global medical technology company specializing in the design, development and manufacture of healthcare solutions for pain management, enteral feeding and respiratory care. Its product portfolio includes infusion systems and surgical fluid warming devices for enhanced patient comfort, regional anesthesia pumps and catheter‐based therapies for post‐operative pain control, as well as feeding tube and pump technologies that support enteral nutrition for critically ill patients. Through its respiratory care offerings, Avanos provides airway clearance and breathing assistance products for individuals with chronic respiratory conditions.
Founded in 2014 as a spin‐off from Kimberly‐Clark’s healthcare business, Avanos has built upon decades of medical device experience to establish a broad global footprint. The company’s flagship brands encompass on‐demand analgesia systems, such as the ON-Q® and PainBuster® families, along with Volara® warming platforms and a range of feeding and respiratory solutions marketed under proprietary names. These products are distributed to hospitals, surgical centers and home healthcare providers in more than 70 countries.
Headquartered in Alpharetta, Georgia, Avanos operates manufacturing facilities across North America, Europe and Asia, supported by research and development centers that focus on human factors engineering and clinical innovation. Its leadership team draws on deep expertise in medical device commercialization, quality assurance and regulatory affairs, while the board of directors includes veterans of global healthcare and industrial technology sectors. Together, they guide Avanos’s strategy of expanding its core franchises and exploring adjacent therapy areas.
Looking ahead, Avanos Medical continues to invest in next‐generation delivery systems, minimally invasive pain management technologies and enhanced nutritional products. By leveraging clinical partnerships and a growing international sales organization, the company aims to drive sustainable growth and deliver value to both patients and healthcare customers worldwide.
